Literature DB >> 23343198

Neurocognitive deficits associated with the hepatitis C virus among incarcerated men.

Tracie M Umaki1, Robert L Denney.   

Abstract

The purpose of this preliminary study was to examine cognitive functioning in inmates with the hepatitis C virus (HCV) and to investigate relationships among performance on the Repeatable Battery for the Assessment of Neuropsychological Status-Form A (RBANS; Randolph, 1998). Data from 43 HCV+ inmates were reviewed retrospectively and compared with a sample of HCV- inmates. Significant differences were found on two of five indices (Attention: U = 537.5, p = .003; r = -.32; Total: U = 643.0, p = .048; r = -.22) and four subtests: Coding (U = 326.0, p <.001, r = -.53), Digit Span (U = 634.0, p = .038, r = -.22), Story Memory (U = 625.5, p = .032, r = -.24), and Story Recall (U = 548.5, p = .004, r = -.31), with the HCV group scoring lower on all significant measures. In this study the RBANS proved to be an efficient measure with clinical utility among an HCV population. Within this incarcerated population patterns of performance were "typical" of current literature, with impaired attention appearing earlier in the disease process, and the study invites further exploration into proposed cognitive deficits among this population where HCV is highly prevalent.

Entities:  

Mesh:

Year:  2013        PMID: 23343198     DOI: 10.1080/13854046.2012.758315

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   3.535


  2 in total

1.  RBANS Validity Indices: a Systematic Review and Meta-Analysis.

Authors:  Robert D Shura; Timothy W Brearly; Jared A Rowland; Sarah L Martindale; Holly M Miskey; Kevin Duff
Journal:  Neuropsychol Rev       Date:  2018-05-16       Impact factor: 7.444

Review 2.  Hepatitis C virus as a systemic disease: reaching beyond the liver.

Authors:  Kirat Gill; Hasmik Ghazinian; Richard Manch; Robert Gish
Journal:  Hepatol Int       Date:  2015-12-10       Impact factor: 6.047

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.